PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+24.32%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.14B
AUM Growth
+$1.14B
(+27%)
Cap. Flow
+$35.2M
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
66.05%
Holding
127
New
33
Increased
28
Reduced
22
Closed
24
Top Buys
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$69.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$41.4M |
| 3 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$34.8M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$23M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$19.4M |
Top Sells
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$107M |
| 2 |
Biogen
BIIB
|
$49.8M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$31.3M |
| 4 |
Lisata Therapeutics
LSTA
|
$25.5M |
| 5 |
STML
Stemline Therapeutics, Inc.
STML
|
$22.7M |
Sector Composition
| 1 | Healthcare | 82.97% |
| 2 | Financials | 0.01% |
| 3 | Consumer Staples | 0.01% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGR
1
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $200M | 16.2% | 2,328,341 -1,245,085 | -35% | -$107M |
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $131M | 10.62% | 2,772,069 +49,981 | +2% | +$2.36M |
|
|
ONXX
3
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $69.5M | 5.64% | +556,944 | New | +$69.5M |
|
4
Talphera
TLPH
$11.1M
| $63.2M | 5.13% | 5,858,400 +850,000 | +17% | +$9.16M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $58.6M | 4.76% | 1,513,644 +593,150 | +64% | +$23M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $56.2M | 4.56% | 364,619 +268,363 | +279% | +$41.4M |
|
7
Gilead Sciences
GILD
$140B
| $54.3M | 4.41% | 864,070 +75,710 | +10% | +$4.76M |
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $48.3M | 3.92% | 4,270,704 -811,013 | -16% | -$9.18M |
|
|
RPRX
9
DELISTED
Repros Therapeutics Inc.
RPRX
| $39.7M | 3.22% | 1,481,733 +1,300,303 | +717% | +$34.8M |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $34.3M | 2.78% | 452,095 +195,548 | +76% | +$14.8M |
|
|
QCOR
11
DELISTED
QUESTCOR PHARMA INC
QCOR
| $21.8M | 1.77% | 376,350 +334,164 | +792% | +$19.4M |
|
12
Exact Sciences
EXAS
$8.98B
| $20.6M | 1.67% | 1,748,314 +98,756 | +6% | +$1.17M |
|
13
Viatris
VTRS
$12.3B
| $17.6M | 1.43% | +460,305 | New | +$17.6M |
|
14
Cigna
CI
$80.3B
| $17.1M | 1.39% | 222,848 +222,558 | +76,744% | +$17.1M |
|
|
NEPT
15
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $17.1M | 1.39% | 5,383,857 -39,063 | -0.7% | -$124K |
|
16
Acadia Pharmaceuticals
ACAD
$4.38B
| $16.8M | 1.36% | 610,615 -116,014 | -16% | -$3.19M |
|
17
Madrigal Pharmaceuticals
MDGL
$9.76B
| $15M | 1.22% | 2,381,236 -312,000 | -12% | -$1.97M |
|
|
HNT
18
DELISTED
HEALTH NET INC
HNT
| $14.4M | 1.17% | +453,780 | New | +$14.4M |
|
19
Pacira BioSciences
PCRX
$1.2B
| $13.1M | 1.06% | +272,034 | New | +$13.1M |
|
20
Sonida Senior Living
SNDA
$488M
| $13M | 1.05% | 614,089 -277,319 | -31% | -$5.87M |
|
|
COV
21
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $12.9M | 1.04% | 211,245 +143,745 | +213% | +$8.76M |
|
|
SNTS
22
DELISTED
SANTARUS INC
SNTS
| $12M | 0.98% | 532,243 -92,757 | -15% | -$2.1M |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.8M | 0.96% | 194,701 +53,874 | +38% | +$3.28M |
|
|
DYAX
24
DELISTED
DYAX CORPORATION
DYAX
| $11.6M | 0.94% | 1,692,912 -29,590 | -2% | -$203K |
|
|
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $11.3M | 0.92% | +6,994,673 | New | +$11.3M |
|